← All companies

ADCT

ADC Therapeutics SA

ADCT NYSE Pharmaceutical Preparations EDGAR ↗

$1.05

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$134M

Revenue (TTM)

$84.0M

Net income (TTM)

-$137M

EPS (TTM)

$-0.97

P/E ratio

—

Dividend yield

—

Free cash flow

-$141M

Cash

$231M

Total assets

$291M

Gross margin

—

52-week range

$0.78 – $4.98

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 2, 2026 8-K Regulation FD disclosure; Other events Jun 24, 2026 8-K Regulation FD disclosure; Other events Jun 3, 2026 8-K Shareholder vote results Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 23, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2026 8-K Other events Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity Oct 14, 2025 8-K Regulation FD disclosure Sep 30, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Entered a material agreement; Exit or disposal costs; Unregistered sale of equity Jun 12, 2025 8-K Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Shareholder vote results Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Shareholder vote results Jun 14, 2024 8-K Regulation FD disclosure May 14, 2024 8-K Other events May 8, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2024 8-K Regulation FD disclosure Apr 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release) Mar 13, 2024 8-K Regulation FD disclosure Mar 5, 2024 8-K Director or officer change Feb 29, 2024